.Bristol Myers Squibb has possessed a whiplash change of mind on its own BCMA bispecific T-cell enga...
.Charles Baum, M.D., Ph.D., that managed Mirati Therapeutics' $ 5.8 billion purchase to Bristol Myer...
.After communicating to more than 200 companies to companion a Tourette disorder treatment that pres...
.Novartis has had some rotten luck with bispecific antitoxins in the past, however judging by the ph...
.Pinetree Rehabs will help AstraZeneca plant some trees in its pipeline with a brand-new treaty to e...